Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$0.4 - $0.63 $89,036 - $140,231
-222,590 Reduced 17.55%
1,045,426 $447,000
Q2 2023

Aug 11, 2023

BUY
$0.51 - $0.67 $229,851 - $301,962
450,690 Added 55.14%
1,268,016 $699,000
Q1 2023

May 12, 2023

SELL
$0.6 - $0.91 $280,260 - $425,061
-467,100 Reduced 36.37%
817,326 $540,000
Q4 2022

Feb 13, 2023

BUY
$0.48 - $5.33 $616,524 - $6.85 Million
1,284,426 New
1,284,426 $809,000
Q2 2022

Aug 12, 2022

BUY
$4.21 - $11.15 $1.49 Million - $3.96 Million
355,035 New
355,035 $1.64 Million

Others Institutions Holding TIL

About Instil Bio, Inc.


  • Ticker TIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,694,000
  • Market Cap $2.82B
  • Description
  • Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...
More about TIL
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.